Transtracheal oxygen catheters.
Over the past 20 years a variety of transtracheal catheters have been developed for long-term oxygen therapy. A modified Seldinger technique has been the standard in the past, but a more recent procedure for surgical creation of the tracheocutaneous tract presents a number of potential advantages. TTO should be administered as a program of care, and recent advances with a streamlined and shortened program have simplified and improved the delivery of a technology that has a number of potential benefits and established safety. TTO may further increase the oxygen conservation efficiency of demand oxygen controller devices, and studies have shown TTO to be a potential alternative to nasal oxygen, continuous positive airway pressure, and tracheotomy for severe obstructive sleep apnea. Very high flows (> 10 L/minute) of a humidified air/oxygen blend, termed transtracheal augmented ventilation, extend the physiologic benefits of TTO and have promise in both the outpatient nocturnal ventilatory support of patients with severe respiratory disease and in liberation of patients from prolonged mechanical ventilation.
Christopher
Kent L
KL
University of Colorado Health Sciences Center, Denver, CO 80231, USA. drkchristopher@attbi.com
D000818:Animals; D002404:Catheterization; D006801:Humans; D010100:Oxygen / Q000008:administration & dosage*; D012121:Respiration, Artificial; D020181:Sleep Apnea, Obstructive / Q000628:therapy
D010100:Oxygen